Mantle Cell Lymphoma: CALQUENCE is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
Chronic Lymphocytic Leukemia: CALQUENCE is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL).